The table below shows Bionano Genomics, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
-
-
-
-
-
-
Cost of revenue
$15.32M
$30.40M
$26.55M
$21.86M
$14.11M
$5.73M
Gross profit
-
-
-
-
-
-
R&D
$11.37M
$24.80M
$54.03M
$49.05M
$22.48M
$10.26M
SG&A
$35.15M
BNGO annual revenue (10-K history)
Bionano Genomics, Inc. reported annual revenue of $28.51M for fiscal year 2025. That is down 7.4% from $30.78M in fiscal 2024. Over the 9 fiscal years shown, annual revenue grew from $9.51M (FY 2017) to $28.51M. Figures come from the company's audited annual reports as filed with the SEC.